Church & Dwight Gummy Investment Targets Expanding Market

Church & Dwight expands its manufacturing capacity for gummy vitamins, citing strong sales growth in the category, and expects to use the format for some OTC products. Analysts expect interest in the gummy format to spread amongst manufacturers across the consumer health space.

Church & Dwight Co. Inc. expanded its production capacity for L’il Critters children’s and Vitafusion adult vitamin lines by 75% with an eye on gummy products’ potential to grow into a substantial piece of the dietary supplement market.

More from United States

US FDA Finds ‘Significant’ Data Integrity Breaches In CRO Raptim Studies

 

The US FDA has deemed certain in vitro bioequivalence studies conducted by CRO Raptim Research “not acceptable” and raised concerns over its in vivo study methods.

US Pharma Tariff Reprieve May Be Ending

 

Sector-specific tariffs, including on pharmaceuticals, could be announced as early as this week.

Missing BsUFA Revenue Trigger Could Open US FDA Staff To Criminal Penalty

 

Massive layoffs and the biosimilar user fee program’s historic flirtation with the non-user fee spending requirements raise concerns that the FDA could lose its ability to collect BsUFA revenue, which could mean a fine or jail time for agency staff.

Trump’s US FDA Takeover Similar To Flat Earth Proponents Running NASA, Woodcock Says

 
• By 

The former principal deputy commissioner said the “decapitation” of senior leadership will make resolving internal disputes more difficult, which will slow application reviews. Woodcock also called the FDA layoffs a slow-moving catastrophe.

More from North America